71 Results for "

AsPC-1

" in MedChemExpress (MCE) Product Catalog:
Products (71)

71 Results for "AsPC-1" in MCE Product Catalog:

20
20 Publications Verification
Art. -Nr.: HY-13594
CAS. Nr.: 19660-77-6
Reinheit:  98.31%
Synonyms: Ce6
Forschungsgebiete:  

Infection Cancer

Chlorin e6 is a photosensitizer and has strong absorption peaks at wavelength of 402 and 662 nm, as well as exhibiting intense fluorescence at 668 nm. Chlorin e6 has antimicrobial efficacy and anticancer activity. Chlorin e6 induces cell apoptosis via caspase-3 activation and can be used for the research of cancer [1] .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-B0113
CAS. Nr.: 73590-58-6
Synonyms: H 16868
Omeprazole (H 16868) is an orally active H +,K +-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects [1] .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-10805
CAS. Nr.: 871224-64-5
Reinheit:  99.46%
Synonyms: ACT 078573
Almorexant (ACT 078573) is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively. Almorexant reversibly blocks signaling of orexin-A and orexin-B peptides. Almorexant totally blocked the intracellular Ca 2+ signal pathway. Almorexant stimulates caspase-3 activity in AsPC-1 cells and induces apoptosis [1] .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-10805A
CAS. Nr.: 913358-93-7
Reinheit:  99.98%
Synonyms: ACT 078573 hydrochloride
Almorexant (ACT 078573) hydrochloride is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively. Almorexant hydrochloride reversibly blocks signaling of orexin-A and orexin-B peptides. Almorexant hydrochloride totally blocked the intracellular Ca 2+ signal pathway. Almorexant hydrochloride stimulates caspase-3 activity in AsPC-1 cells and induces apoptosis [1] .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-114657A
CAS. Nr.: 19428-14-9
Reinheit:  99.93%
Target:  

Arp2/3 Complex

Forschungsgebiete:  

Inflammation/Immunology Cancer

Benproperine phosphate is an orally active, potent actin-related protein 2/3 complex subunit 2 (ARPC2) inhibitor. Benproperine phosphate attenuates the actin polymerization rate of action polymerization nucleation by impairing Arp2/3 function. Benproperine phosphate has the potential for a cough suppressant and suppresses cancer cell migration and tumor metastasis [1].
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-148098
CAS. Nr.: 2791263-84-6
Reinheit:  99.31%
Synonyms: Pan KRas-IN-1
Target:  

Ras

Forschungsgebiete:  

Cancer

AM-2383 is a pan KRas inhibitor, can be used for agent resistance in cancer developed with KRas G12C inhibitors [1].
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-148685
CAS. Nr.: 26530-26-7
Reinheit:  98.76%
Forschungsgebiete:  

Cancer

KM04416, an isothiazolone derivative, is a potent glycerol-3-phosphate dehydrogenase (GPD2) inhibitor. KM04416 significantly inhibits PNT1A cell proliferation [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P10387
Forschungsgebiete:  

Cancer

RSM3 is a METTL3-METTL14 complex inhibitor with a Kd of 3.10 μM for the METTL3-METTL14 complex. RSM3 reduces the m 6A modification level of SLC31A1 and the global RNA methylation level. RSM3 upregulates programmed cell death-related genes, enhances cell apoptosis, inhibits pro-cancer signals and suppresses tumor growth. RSM3 is applicable to the research of preeclampsia and cancer [1] .
loading...
    loading...
Art. -Nr.: HY-148273
CAS. Nr.: 2821793-99-9
Reinheit:  99.42%
Synonyms: ASP-3082; KRAS G12D inhibitor 17
Target:  

PROTACs Ras ERK Akt

Forschungsgebiete:  

Cancer

Setidegrasib (ASP-3082) is a PROTAC KRAS degrader (DC50: 37 nM). Setidegrasib induces the degradation of G12D-mutation KRAS protein. Setidegrasib suppresses p-ERK, p-AKT, p-S6 levels in AsPC-1 cells. Setidegrasib exhibits anti-tumor activity in various cancer xenograft models in mice. Setidegrasib can be used in studies involving KRAS(G12D)-mutated solid tumors, such as non-small cell lung cancer [1] .
loading...
    loading...
Art. -Nr.: HY-158409
CAS. Nr.: 3034673-92-9
Reinheit:  98.00%
Forschungsgebiete:  

Cancer

Pan-rasin-2 (compound 6A) is an orally active molecular glues that targets RAS. Pan-RAS-IN-2 inhibits pERK (IC50 in AsPC-1 cells: 0.3 nM). Pan-rasin-2 has significant inhibitory activity on cell proliferation of RAS mutant cell lines. Pan-rasin-2 can form ternary complexes with cyclophilin A (CYPA) and RAS (ON) proteins and the formation of ternary complexes can block the binding of RAF downstream of RAS, which has anti-tumor (such as colorectal cancer, pancreatic cancer) effects [1].
loading...
    loading...
Art. -Nr.: HY-161176
CAS. Nr.: 3033583-54-6
Target:  

PROTACs Ras ERK

Forschungsgebiete:  

Cancer

PROTAC KRAS G12D degrader 1 is a selective PROTAC KRAS G12D degrader. PROTAC KRAS G12D degrader 1 inhibits proliferation of KRAS G12D-mutant cells and suppresses ERK phosphorylation. PROTAC KRAS G12D degrader 1 inhibits tumor growth in mice bearing AsPC-1 xenografts. PROTAC KRAS G12D degrader 1 can be used for the study of KRAS G12D-driven cancers.(Pink: KRAS ligand (HY-175892), Blue: VHL Ligand (HY-112078), Black: Linker, E3 ligase ligand-linker conjugate (HY-175893)) [1].
loading...
    loading...
Art. -Nr.: HY-176134
CAS. Nr.: 3030493-05-8
Target:  

PROTACs Ras

Forschungsgebiete:  

Cancer

RP03707 is a PROTAC degrader of KRAS G12D. RP03707 forms a ternary complex with KRAS G12D and the CRBN E3 ligase, promoting the ubiquitination and proteasomal degradation of KRAS G12D. RP03707 inhibits the growth of KRAS G12D-positive tumor cells [1].
loading...
    loading...
Art. -Nr.: HY-174304
Forschungsgebiete:  

Cancer

Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide is a drug-linker conjugates for ADC. Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide consists of Triptolide (HY-32735) and a stable cleavable linker (Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-Cl) (HY-174810). Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide can be used for the synthesis of antibody-drug conjugates (ADCs) [1].
loading...
    loading...
Art. -Nr.: HY-164350
CAS. Nr.: 3033690-83-1
Target:  

Ras ERK p38 MAPK

Forschungsgebiete:  

Cancer

KRAS inhibitor-27 (Compound 15h) is the inhibitor for KRAS. KRAS inhibitor-27 inhibits KRAS G12D/G12V mutated cells AsPC-1, SW620 and KRAS wildtype cell HT-29 with IC50 of 378, 0.6 and 3230 nM, respectively. KRAS inhibitor-27 inhibits ERK phosphorylation (IC50 in cell AsPC-1 and SW620 is 0.6 nM and 1 nM), reduces the expression of DUSP4, thereby inhibiting MAPK signaling pathway [1].
loading...
    loading...
Art. -Nr.: HY-162809
CAS. Nr.: 2251130-41-1
Target:  

Ras

Forschungsgebiete:  

Cancer

XMU-MP-9 is a bifunctional compound that binds to the C2 domain of Nedd4-1 and the allosteric site of K-Ras. XMU-MP-9 enhances the interaction between Nedd4-1 and K-Ras, induces conformational changes in the Nedd4-1/K-Ras complex, promotes the ubiquitination and degradation of multiple K-Ras mutants, and inhibits the proliferation of cells carrying K-Ras mutants. XMU-MP-9 can be used for the study of colon, lung and pancreatic cancer [1].
loading...
    loading...
Art. -Nr.: HY-175870
CAS. Nr.: 3024878-19-8
Target:  

Ras ERK

Forschungsgebiete:  

Cancer

Eras-4001 is a potent, orally active pan-KRAS inhibitor with Kd values of 110, 13 and 39 pM against wild-type, G12D and G12V mutant KRAS, respectively, and exhibits selectivity toward wild-type HRAS and NRAS. Eras-4001 inhibits ERK1/2 phosphorylation and cell viability in cancer cells. Eras-4001 induces tumor growth inhibition and regression in subcutaneous xenograft models. Eras-4001 can be used in research on non-small cell lung cancer, ovarian cancer, etc. [1]
loading...
    loading...
Art. -Nr.: HY-178836
CAS. Nr.: 3077488-78-6
Forschungsgebiete:  

Cancer

Z56-L23 is a conjugate of RAS-targeting ADC cytotoxic payload-linker with anti-tumor activity. Z56-L23 can be conjugated with HER3 antibody, EGFR antibody or EGFRxHER3 bispecific antibody to form intact antibody-drug conjugates (ADCs). ADC molecules related to Z56-L23 effectively inhibit the proliferation of tumor cells and also significantly suppress tumor growth in xenograft mouse models. Z56-L23 can be used in the research of pancreatic cancer [1].
loading...
    loading...
Art. -Nr.: HY-157029S
Reinheit:  98.07%
KRASG12D-IN-1 (compound 22) is a KRAS G12D Inhibitor. KRASG12D-IN-1 has dose-dependent anti-tumor efficacy in the AsPC-1 xenograft mouse models with a tumor growth inhibition [1].
loading...
    loading...
Art. -Nr.: HY-14653
CAS. Nr.: 125973-56-0
Reinheit:  99.67%
Synonyms: TAC-101; Am 555S
Target:  

RAR/RXR Apoptosis

Forschungsgebiete:  

Cancer

Amsilarotene (TAC-101; Am 555S), an orally active synthetic retinoid, has selective affinity for retinoic acid receptor α (RAR-α) binding with Ki of 2.4, 400 nM for RAR-α and RAR-β. Amsilarotene induces the apoptotic of human gastric cancer, hepatocellular carcinoma and ovarian carcinoma cells. Amsilarotene can be used for the research of cancer [1] .
loading...
    loading...
Art. -Nr.: HY-158008
CAS. Nr.: 2946593-60-6
Target:  

Ras

Forschungsgebiete:  

Cancer

(R)-G12Di-7 is a covalent ligand for KRAS-G12D, which selectively labels K-Ras-G12D·GDP and K-Ras-G12D·GppNHp. (R)-G12Di-7 exhibits inhibitory activity against G12D mutated cancer cells [1].
loading...
    loading...